NO2994485T3 - - Google Patents

Info

Publication number
NO2994485T3
NO2994485T3 NO14722194A NO14722194A NO2994485T3 NO 2994485 T3 NO2994485 T3 NO 2994485T3 NO 14722194 A NO14722194 A NO 14722194A NO 14722194 A NO14722194 A NO 14722194A NO 2994485 T3 NO2994485 T3 NO 2994485T3
Authority
NO
Norway
Application number
NO14722194A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2994485T3 publication Critical patent/NO2994485T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/12Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Sustainable Development (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Water Supply & Treatment (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
NO14722194A 2013-05-06 2014-05-06 NO2994485T3 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13305593 2013-05-06
PCT/EP2014/059246 WO2014180852A1 (fr) 2013-05-06 2014-05-06 Procédé continu à étapes multiples pour la purification d'anticorps
EP14722194.9A EP2994485B1 (fr) 2013-05-06 2014-05-06 Procede continu en plusieurs etapes destine a la purification des anticorps

Publications (1)

Publication Number Publication Date
NO2994485T3 true NO2994485T3 (fr) 2018-06-09

Family

ID=48430636

Family Applications (1)

Application Number Title Priority Date Filing Date
NO14722194A NO2994485T3 (fr) 2013-05-06 2014-05-06

Country Status (19)

Country Link
US (1) US10793622B2 (fr)
EP (2) EP3301115B1 (fr)
JP (2) JP6463734B2 (fr)
KR (1) KR102272851B1 (fr)
CN (2) CN116003579A (fr)
AU (1) AU2014264697B2 (fr)
BR (1) BR112015027812B1 (fr)
CA (1) CA2911462C (fr)
CY (1) CY1125281T1 (fr)
DK (2) DK3301115T3 (fr)
ES (2) ES2665645T3 (fr)
HU (2) HUE057119T2 (fr)
IL (1) IL242408B (fr)
MX (1) MX368177B (fr)
NO (1) NO2994485T3 (fr)
RU (1) RU2662668C2 (fr)
SG (1) SG11201508968XA (fr)
TW (2) TWI631132B (fr)
WO (1) WO2014180852A1 (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
US9458450B2 (en) 2012-03-15 2016-10-04 Flodesign Sonics, Inc. Acoustophoretic separation technology using multi-dimensional standing waves
US10967298B2 (en) 2012-03-15 2021-04-06 Flodesign Sonics, Inc. Driver and control for variable impedence load
US9950282B2 (en) 2012-03-15 2018-04-24 Flodesign Sonics, Inc. Electronic configuration and control for acoustic standing wave generation
CN111172135A (zh) * 2012-10-24 2020-05-19 建新公司 使用mes和mops作为流动相改性剂从多峰树脂洗脱生物分子
CN105555795A (zh) * 2013-09-17 2016-05-04 株式会社钟化 新抗体纯化方法和由该方法得到的抗体、以及使用了阳离子交换基团的新抗体纯化法和由该方法得到的抗体
WO2015105955A1 (fr) 2014-01-08 2015-07-16 Flodesign Sonics, Inc. Dispositif d'acoustophorèse avec double chambre acoustophorétique
GB201503578D0 (en) * 2015-03-03 2015-04-15 Ge Healthcare Bio Sciences Ab Sanitization method for affinity chromatography matrices
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11021699B2 (en) 2015-04-29 2021-06-01 FioDesign Sonics, Inc. Separation using angled acoustic waves
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
EP3015542A1 (fr) * 2015-05-07 2016-05-04 Bayer Technology Services GmbH Installation modulaire et procédé de production continue, présentant une réduction de germe et/ou préparation d'un produit
US11474085B2 (en) 2015-07-28 2022-10-18 Flodesign Sonics, Inc. Expanded bed affinity selection
US11459540B2 (en) 2015-07-28 2022-10-04 Flodesign Sonics, Inc. Expanded bed affinity selection
US20170101437A1 (en) * 2015-10-09 2017-04-13 Hetero Drugs Ltd. Process for purification of darbepoetin alfa
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
US11085035B2 (en) 2016-05-03 2021-08-10 Flodesign Sonics, Inc. Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
US20190211055A1 (en) * 2016-09-14 2019-07-11 Kinbio Ltd. Methods of purifying and qualifying antibodies
EP3529347A1 (fr) 2016-10-19 2019-08-28 Flodesign Sonics, Inc. Extraction par affinité de cellules par un procédé acoustique
CA3057286A1 (fr) * 2017-03-24 2018-09-27 Council Of Scientific And Industrial Research Procede de purification de fragments d'anticorps recombinants
GB201711481D0 (en) * 2017-07-17 2017-08-30 Ucb Biopharma Sprl Protein purification
EP3676375A4 (fr) 2017-08-31 2021-04-07 Green Cross Corporation Procédé de purification d'une protéine de sulfatase
KR102439221B1 (ko) 2017-12-14 2022-09-01 프로디자인 소닉스, 인크. 음향 트랜스듀서 구동기 및 제어기
EP3769083A1 (fr) 2018-03-21 2021-01-27 Waters Technologies Corporation Préparation d'échantillon à base d'affinité élevée sans anticorps, sorbants, dispositifs et méthodes
EP3546475A1 (fr) * 2018-03-27 2019-10-02 Sanofi Processus d'écoulement intégral pour purifier des protéines recombinées
US20190367858A1 (en) * 2018-06-01 2019-12-05 Lonza Ltd. Midscale Model For Organic Growth and Phasing
KR102337683B1 (ko) * 2018-09-21 2021-12-13 주식회사 녹십자 고효율 항-tfpi 항체 조성물
EP3636657A1 (fr) * 2018-10-08 2020-04-15 Ablynx N.V. Procédé de purification d'anticorps sans chromatographie
WO2020084503A1 (fr) * 2018-10-26 2020-04-30 Cadila Healthcare Limited Composition comprenant un anticorps ayant un niveau réduit de variants basiques de celui-ci
WO2020183332A1 (fr) * 2019-03-11 2020-09-17 Intas Pharmaceuticals Ltd. Purification d'adalimumab à l'aide d'une chromatographie en tandem
EP3947705A1 (fr) * 2019-04-03 2022-02-09 Genzyme Corporation Production en continu de protéines recombinées
WO2020258704A1 (fr) * 2019-06-28 2020-12-30 信达生物制药(苏州)有限公司 Procédé chromatographique à écoulement continu sans interruption
KR102154952B1 (ko) * 2020-02-21 2020-09-10 프레스티지바이오로직스 주식회사 아달리무맙의 Non-Protein A 정제방법
CN112574321B (zh) * 2020-12-30 2023-10-20 上海赛金生物医药有限公司 一种捕获单克隆抗体-肿瘤坏死因子融合蛋白的亲和纯化方法
WO2022234412A1 (fr) 2021-05-03 2022-11-10 Lupin Limited Procédé de purification de protéines de fusion fc

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2070855T5 (es) 1987-10-23 2004-03-01 Schering Corporation Metodo para purificar una proteina.
ES2126775T3 (es) 1993-09-21 1999-04-01 Hemosol Inc Procedimiento cromatografico de desplazamiento y producto de hemoglobina purificada.
CA2106612C (fr) 1993-09-21 2001-02-06 Diana Pliura Processus de chromatographie a deplacement
US5891741A (en) 1997-05-16 1999-04-06 Coulter International Corp. Antibody-aminodextran-phycobiliprotein conjugates
CN1136317C (zh) 1999-03-12 2004-01-28 中国人民解放军第四军医大学 单克隆抗体双段和单段的制备方法
US20020009445A1 (en) 2000-07-12 2002-01-24 Yansheng Du Human beta-amyloid antibody and use thereof for treatment of alzheimer's disease
US6602855B2 (en) 2001-04-30 2003-08-05 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons
CN1504482A (zh) 2002-12-03 2004-06-16 北京优力凯生物技术有限责任公司 无细胞百日咳抗原蛋白的分离纯化方法
EP2468769A1 (fr) 2004-04-21 2012-06-27 The Brigham and Women's Hospital, Inc. Peptides à liaison de glucosamine poly-N-acétyle (PNAG/DPNAG) et procédés d'utilisation
US7714112B2 (en) * 2004-10-21 2010-05-11 Ge Healthcare Bio-Sciences Ab Method of antibody purification
IL296666A (en) 2005-03-23 2022-11-01 Genmab As Antibodies against 38cd for the treatment of multiple myeloma
CN1814775A (zh) 2005-12-06 2006-08-09 中国海洋大学 一种抗病毒活性寡聚肽的制备方法
EP1914242A1 (fr) * 2006-10-19 2008-04-23 Sanofi-Aventis Nouveau anticorps Anti-CD38 pour le traitement du cancer
DE602008005885D1 (de) 2007-07-11 2011-05-12 Novo Nordisk As Aufreinigung von faktor viii unter verwendung eine
ES2639016T3 (es) 2007-11-16 2017-10-25 The Rockefeller University Anticuerpos específicos para la forma protofibrilar de proteína beta-amiloide
TWI472339B (zh) * 2008-01-30 2015-02-11 Genentech Inc 包含結合至her2結構域ii之抗體及其酸性變異體的組合物
EP2615112A3 (fr) * 2008-02-29 2013-08-21 Biogen Idec MA Inc. Protéines de fusion d'immunoglobuline purifiées et leurs procédés de purification
WO2009138484A2 (fr) 2008-05-15 2009-11-19 Novo Nordisk A/S Procédé de purification d'anticorps
BRPI0915948A2 (pt) * 2008-07-18 2019-04-09 Talecris Biotherapeutics Inc método de preparar inibidor de alfa-1 proteinase
JPWO2010071208A1 (ja) 2008-12-19 2012-05-31 武田薬品工業株式会社 抗体の精製方法
US20120022239A1 (en) 2009-01-13 2012-01-26 Ge Healthcare Bio-Sciences Ab Precipitation of biomolecules with negatively charged polymers
KR101224468B1 (ko) * 2009-05-20 2013-01-23 주식회사 파멥신 신규한 형태의 이중표적항체 및 그 용도
CN107188960A (zh) * 2009-08-07 2017-09-22 Emd密理博公司 从样品的一或多种杂质中纯化靶蛋白的方法
US9527010B2 (en) * 2009-09-25 2016-12-27 Ge Healthcare Bio-Sciences Corp. Separation system and method
US20120208986A1 (en) * 2009-10-20 2012-08-16 Wenger Marc D Use of mixed mode chromatography for the capture and purification of basic antibody products
US20130178608A1 (en) 2009-12-29 2013-07-11 Samir Kulkarni Protein purification by ion exchange
ES2534936T3 (es) 2010-08-02 2015-04-30 Ratiopharm Gmbh Método para producir y purificar una sialiltransferasa soluble activa
WO2012125735A1 (fr) * 2011-03-15 2012-09-20 Abott Laboratories Approche intégrée à isolement et purification d'anticorps
KR102058254B1 (ko) * 2011-03-29 2019-12-20 글락소스미스클라인 엘엘씨 단백질 정제용 완충제 시스템
US8445284B2 (en) 2011-06-17 2013-05-21 Constitution Medical, Inc. Fixative and staining solutions
WO2013028330A2 (fr) 2011-08-19 2013-02-28 Emd Millipore Corporation Procédés pour réduire le niveau d'une ou de plusieurs impuretés dans un échantillon pendant un procédé de purification de protéines
EP2578286A1 (fr) * 2011-10-04 2013-04-10 Merck Patent GmbH Procédé et appareil de purification chromatographique
PE20141413A1 (es) * 2011-10-25 2014-10-25 Onclave Therapeutics Ltd Formulaciones de anticuerpo y metodos
WO2013075740A1 (fr) 2011-11-23 2013-05-30 Sanofi Procédé de purification d'anticorps

Also Published As

Publication number Publication date
HUE057119T2 (hu) 2022-04-28
IL242408B (en) 2020-04-30
EP2994485A1 (fr) 2016-03-16
DK3301115T3 (da) 2022-01-31
AU2014264697A1 (en) 2015-11-26
HUE038741T2 (hu) 2018-11-28
BR112015027812A2 (pt) 2017-07-25
BR112015027812B1 (pt) 2021-03-30
CY1125281T1 (el) 2023-06-09
CN116003579A (zh) 2023-04-25
KR20160005047A (ko) 2016-01-13
CA2911462C (fr) 2021-04-06
JP2016519137A (ja) 2016-06-30
SG11201508968XA (en) 2015-11-27
DK2994485T3 (en) 2018-04-23
TWI631132B (zh) 2018-08-01
JP2019104735A (ja) 2019-06-27
RU2662668C2 (ru) 2018-07-26
TW201908331A (zh) 2019-03-01
ES2665645T3 (es) 2018-04-26
CN105358572A (zh) 2016-02-24
ES2905675T3 (es) 2022-04-11
MX2015015482A (es) 2016-03-21
TW201522363A (zh) 2015-06-16
RU2015151869A (ru) 2017-06-13
KR102272851B1 (ko) 2021-07-02
EP3301115B1 (fr) 2021-11-10
US10793622B2 (en) 2020-10-06
MX368177B (es) 2019-09-23
EP2994485B1 (fr) 2018-01-10
JP6463734B2 (ja) 2019-02-06
WO2014180852A1 (fr) 2014-11-13
CA2911462A1 (fr) 2014-11-13
AU2014264697B2 (en) 2019-08-22
US20160083454A1 (en) 2016-03-24
TWI675041B (zh) 2019-10-21
EP3301115A1 (fr) 2018-04-04

Similar Documents

Publication Publication Date Title
AP2016009275A0 (fr)
BR112015007533A2 (fr)
BR102016010778A2 (fr)
BR112014017733A2 (fr)
BR112014017739A2 (fr)
BR112014019326A2 (fr)
NO2994485T3 (fr)
BR112014020341A2 (fr)
BR112014017765A2 (fr)
BR112014017669A2 (fr)
BR112014021878A2 (fr)
BR112016005761A2 (fr)
BR112016000440A2 (fr)
BR112014017901A2 (fr)
BR112014019204A2 (fr)
BR112016000087A2 (fr)
BR112015015948A2 (fr)
BR112014017722A2 (fr)
BR112014018578A2 (fr)
BR112014017653A2 (fr)
BR112016000816A2 (fr)
BR112014017601A2 (fr)
BR112015015312A2 (fr)
BR112015018021A2 (fr)
BR112014017745A2 (fr)